Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.38

-9.0%

Nov 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (10049)	2/27/2004 3:20:24 AM
From: JMarcus	Read Replies (1) of 52153

Today a friend who runs his own small mutual fund emailed me the following info re PCYC: <<PCYC was discussed by an analyst last night at a meeting. He seemed very positive that on March 10, the company would announce the results of a phase 2 trial of their drug as a single agent for lung cancer. It has been used in the past in combination with other treatments.>> Marc

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next